UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Organische Schwefel-Verbindungen

4th Edition.

Volltextzugriff (PDF)

N‑Heterocyclic Carbene Ligand-Controlled Chemodivergent Suzuki–Miyaura Cross Coupling

Journal of organic chemistry, 2019-09, Vol.84 (18), p.11799-11812

2019

Volltextzugriff (PDF)

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Annals of oncology, 2016-11, Vol.27 (11), p.2124-2130

2016

Volltextzugriff (PDF)

Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study

Annals of oncology, 2018-04, Vol.29 (4), p.917-923

2018

Volltextzugriff (PDF)

Correction to N‑Heterocyclic Carbene Ligand-Controlled Chemodivergent Suzuki–Miyaura Cross Coupling

Journal of organic chemistry, 2022-11, Vol.87 (21), p.14991-14992

2022

Volltextzugriff (PDF)

Finding keys to the Peano curve

Acta mathematica Hungarica, 2022, Vol.167 (1), p.255-277

2022

Volltextzugriff (PDF)

Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199

Molecular cancer therapeutics, 2021-12, Vol.20 (12), p.2483-2494

2021

Volltextzugriff (PDF)

Erste klinische und onkologische Erfahrungen mit der Triplet-Therapie beim „high-volume“ metastasierten hormonsensiblen Prostatakarzinom

Urologie (Heidelberg, Germany), 2024-03, Vol.63 (3), p.254-261

2024

Volltextzugriff (PDF)

ICEBERG: A Novel Inhibitor of Interleukin-1β Generation

Cell, 2000-09, Vol.103 (1), p.99-111

2000

Volltextzugriff (PDF)

Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical Prostatectomy

Medicina (Kaunas, Lithuania), 2024-01, Vol.60 (1), p.173

2024

Volltextzugriff (PDF)

Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real‐world setting

Journal of the American Geriatrics Society (JAGS), 2024-09, Vol.72 (9), p.2700-2708

2024

Volltextzugriff (PDF)

The Association between Patient Characteristics and Biochemical Recurrence after Radical Prostatectomy

Medicina (Kaunas, Lithuania), 2024-07, Vol.60 (7), p.1119

2024

Volltextzugriff (PDF)

Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients

The Prostate, 2024-09, Vol.84 (13), p.1189-1197

2024

Volltextzugriff (PDF)

Impact of homologous recombination repair/BReast CAncer ( BRCA ) gene alterations on survival in a real‐world setting of metastatic prostate cancer

BJU international, 2024-07

2024

Volltextzugriff (PDF)

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer

Current oncology (Toronto), 2022-03, Vol.29 (4), p.2385-2394

2022

Volltextzugriff (PDF)

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

International urology and nephrology, 2021-07, Vol.53 (7), p.1297-1303

2021

Volltextzugriff (PDF)

Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy

Medicina (Kaunas, Lithuania), 2023-06, Vol.59 (6), p.1153

2023

Volltextzugriff (PDF)

Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center

Diagnostics (Basel), 2024-06, Vol.14 (11), p.1184

2024

Volltextzugriff (PDF)

Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients

European urology open science (Online), 2024-08, Vol.66, p.46-54

2024

Volltextzugriff (PDF)

Real‐world evidence of outcomes of oligometastatic hormone‐sensitive prostate cancer patients treated with metastasis‐directed therapy

The Prostate, 2023-10, Vol.83 (14), p.1365-1372

2023

Volltextzugriff (PDF)

Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy

Current oncology (Toronto), 2021-11, Vol.28 (6), p.4738-4747

2021

Volltextzugriff (PDF)

Abstract P5-11-07: Real-world predictors of first-line treatment and descriptive outcomes in HR+/HER2− metastatic breast cancer patients in the US

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-07

2020

Volltextzugriff (PDF)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making

Current oncology (Toronto), 2021-06, Vol.28 (3), p.2123-2133

2021

Volltextzugriff (PDF)

Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer

Urologic oncology, 2024-11, Vol.42 (11), p.371-371.e18

2024

Volltextzugriff (PDF)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy

Frontiers in oncology, 2021-07, Vol.11, p.656444-656444

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(78)
Bücher
(1)

Sprache

Englisch
(61)
Deutsch
(17)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Organische Schwefel-Verbindungen

N‑Heterocyclic Carbene Ligand-Controlled Chemodivergent Suzuki–Miyaura Cross Coupling

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study

Correction to N‑Heterocyclic Carbene Ligand-Controlled Chemodivergent Suzuki–Miyaura Cross Coupling

Finding keys to the Peano curve

Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199

Erste klinische und onkologische Erfahrungen mit der Triplet-Therapie beim „high-volume“ metastasierten hormonsensiblen Prostatakarzinom

ICEBERG: A Novel Inhibitor of Interleukin-1β Generation

Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical Prostatectomy

Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real‐world setting

The Association between Patient Characteristics and Biochemical Recurrence after Radical Prostatectomy

Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients

Impact of homologous recombination repair/BReast CAncer ( BRCA ) gene alterations on survival in a real‐world setting of metastatic prostate cancer

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy

Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center

Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients

Real‐world evidence of outcomes of oligometastatic hormone‐sensitive prostate cancer patients treated with metastasis‐directed therapy

Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy

Abstract P5-11-07: Real-world predictors of first-line treatment and descriptive outcomes in HR+/HER2− metastatic breast cancer patients in the US

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making

Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy

Suchergebnisse filtern